- Trials with a EudraCT protocol (105)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
105 result(s) found for: Female Reproductive Tract.
Displaying page 1 of 6.
EudraCT Number: 2018-001481-42 | Sponsor Protocol Number: ITFE-2026-C11 | Start Date*: 2018-10-04 | |||||||||||
Sponsor Name:ITF RESEARCH PHARMA S.L.U. | |||||||||||||
Full Title: Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of a 0.005% estriol vaginal gel in the prevention of recurrent urinary tract infection... | |||||||||||||
Medical condition: Recurrent Urinary Tract Infection (UTI) in postmenopausal women with vaginal atrophy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002214-14 | Sponsor Protocol Number: IHO-0000-REN-0220-S | Start Date*: 2022-12-19 | |||||||||||
Sponsor Name:Klinikum rechts der Isar, Technische Universität München | |||||||||||||
Full Title: Individualized homeopathy to reduce the use of antibiotics in women with recurring uncomplicated urinary tract infections | |||||||||||||
Medical condition: Women with recurring uncomplicated urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002271-42 | Sponsor Protocol Number: 20110512-BG | Start Date*: 2011-10-13 | |||||||||||
Sponsor Name:University Medical Center Goettingen | |||||||||||||
Full Title: | |||||||||||||
Medical condition: uncomplicated urinary tract infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004153-32 | Sponsor Protocol Number: MK-7625A-034 | Start Date*: 2017-07-25 | ||||||||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | ||||||||||||||||||
Full Title: A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Sub... | ||||||||||||||||||
Medical condition: Treatment of complicated urinary tract infection (cUTI), including pyelonephritis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) PL (Completed) GR (Completed) Outside EU/EEA RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-001606-42 | Sponsor Protocol Number: MB0515/1021/04 | Start Date*: 2016-07-04 | |||||||||||
Sponsor Name:VALEAS SPA - INDUSTRIA CHIMICA E FARMACEUTICA | |||||||||||||
Full Title: EXPLORATIVE, RANDOMIZED, PLACEBO CONTROLLED STUDY FOR THE CLINICAL EVALUATION OF PIDOTIMOD IN FEMALE PATIENTS WITH RECURRENT, UNCOMPLICATED URINARY TRACT INFECTIONS. | |||||||||||||
Medical condition: Recurrent uncomplicated urynary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005559-19 | Sponsor Protocol Number: FUR-03-17 | Start Date*: 2021-02-23 | ||||||||||||||||||||||||||
Sponsor Name:ADAMED Pharma S.A. | ||||||||||||||||||||||||||||
Full Title: FRUTI - a phase III, randomized, multicenter, double-blind, active control study to evaluate the efficacy and safety of Furazidin prolonged-release tablets, 200 mg compared with Nitrofurantoin prol... | ||||||||||||||||||||||||||||
Medical condition: uncomplicated lower urinary tract infections (acute or recurrent) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: PL (Completed) HU (Completed) DE (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000963-54 | Sponsor Protocol Number: FUR-PKPD-05-20 | Start Date*: Information not available in EudraCT | ||||||||||||||||||||||||||
Sponsor Name:Adamed Pharma S.A. | ||||||||||||||||||||||||||||
Full Title: Effectiveness and pharmacokinetic /pharmacodynamic study of Furazidin, prolonged- release tablets, 200 mg in the treatment of patients with uncomplicated lower urinary tract infections (acute or re... | ||||||||||||||||||||||||||||
Medical condition: uncomplicated lower urinary tract infections (acute or recurrent) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: PL (Prematurely Ended) DE (Prematurely Ended) HU (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002747-14 | Sponsor Protocol Number: OF_FUM_CT1 | Start Date*: 2021-05-24 | |||||||||||
Sponsor Name:"Olainfarm" AS | |||||||||||||
Full Title: A multi-center, randomized, double-blind, double-dummy, parallel-group, active drug controlled, adaptive, Phase III study to investigate efficacy, safety and tolerability of Furamag (Furaginum solu... | |||||||||||||
Medical condition: Microbiologically confirmed acute uncomplicated lower urinary tract infections in women. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: LT (Prematurely Ended) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001332-26 | Sponsor Protocol Number: IJG-SCOUT-2021 | Start Date*: 2021-09-06 | |||||||||||
Sponsor Name:IDIAP Jordi Gol | |||||||||||||
Full Title: Clinical effectiveness and bacteriological eradication of 3 short-course antibiotic regimens and single-dose of fosfomicyn trometamol for lower urinary tract infections in adult women [SCOUT study]. | |||||||||||||
Medical condition: Uncomplicated Lower urinary tract infections (uLUTI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003599-35 | Sponsor Protocol Number: 10-019-02 | Start Date*: 2012-09-14 | |||||||||||
Sponsor Name:Cook MyoSite, Incorporated | |||||||||||||
Full Title: A Double blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence | |||||||||||||
Medical condition: Female Stress Urinary Incontinence | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004657-24 | Sponsor Protocol Number: 7985 | Start Date*: 2014-10-24 | |||||||||||
Sponsor Name:Southampton University | |||||||||||||
Full Title: A randomised, double-blind, placebo controlled, feasibility study exploring the role of Chinese herbal medicine in the treatment of women with recurrent urinary tract infections. | |||||||||||||
Medical condition: Recurrent urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003466-12 | Sponsor Protocol Number: MCMK0220 | Start Date*: 2022-03-25 | |||||||||||
Sponsor Name:MCM Klosterfrau Vertriebsgesellschaft mbH | |||||||||||||
Full Title: A double-blind, randomised, multi-centre, controlled clinical trial to compare D-mannose versus antibiotic in the treatment of acute uncomplicated lower urinary tract infections in female patients | |||||||||||||
Medical condition: acute uncomplicated lower urinary tract infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022297-14 | Sponsor Protocol Number: 402-C-0903 | Start Date*: 2011-10-27 | |||||||||||
Sponsor Name:Reata Pharmaceuticals, Inc | |||||||||||||
Full Title: Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurence of Renal Events (BEACON) | |||||||||||||
Medical condition: Chronic Kidney Disease Stage 4 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) AT (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) GB (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003327-11 | Sponsor Protocol Number: 3623 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:University of Southampton | |||||||||||||
Full Title: Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen. | |||||||||||||
Medical condition: Acute urinary tract infections. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002235-15 | Sponsor Protocol Number: 999975814 | Start Date*: 2020-01-22 |
Sponsor Name:University of Oslo | ||
Full Title: The effect of methenamine hippurate to reduce antibiotic prescribing due to new episodes of urinary tract infections (UTI) in elderly women with recurrent UTI – a triple-blinded,randomized placebo-... | ||
Medical condition: recurrent urinary tract infection in women | ||
Disease: | ||
Population Age: Elderly | Gender: Female | |
Trial protocol: SE (Completed) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000906-36 | Sponsor Protocol Number: GEB-IAL-2014-01 | Start Date*: 2014-12-09 |
Sponsor Name:Laboratorios Gebro Pharma S.A. | ||
Full Title: Randomized, parallel, multicenter, phase IV clinical trial to assess the efficacy of hyaluronic acid/chondroitin sulfate versus fosfomycin trometamol in recurrent urinary tract infection prevention. | ||
Medical condition: Recurrent urinary tract infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001838-17 | Sponsor Protocol Number: MV140-SLG-003 | Start Date*: 2015-07-17 | |||||||||||
Sponsor Name:Inmunotek, S.L. [...] | |||||||||||||
Full Title: PROSPECTIVE MULTICENTER CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND, PARALLEL-CONTROLLED VERSUS PLACEBO IN A POLYVALENT SUBLINGUAL BACTERIAL VACCINE (IN ORAL MUCOSA) TO THREE MONTHS AND SIX MONTHS IN ... | |||||||||||||
Medical condition: Recurrent Urinary Tract Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004994-94 | Sponsor Protocol Number: 3415A-002 | Start Date*: 2011-12-21 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of a Single Infusion of MK-6072 (Human Monoclonal Antibody to C. difficile toxin B), and MK-... | |||||||||||||
Medical condition: Recurrence of Clostridium difficile infection (CDI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) ES (Completed) DE (Completed) CZ (Completed) FI (Completed) PL (Completed) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000477-21 | Sponsor Protocol Number: 01579 | Start Date*: 2017-03-27 | |||||||||||
Sponsor Name:Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen | |||||||||||||
Full Title: Reducing antibiotic use for uncomplicated urinary tract infection in gen-eral practice by treatment with Uva ursi - a comparative effectiveness trial | |||||||||||||
Medical condition: uncomplicated urinary tract infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000105-23 | Sponsor Protocol Number: DYDRA001 | Start Date*: 2019-03-01 |
Sponsor Name:UZ Brussel | ||
Full Title: Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: pharmacokinetics and the impact on the endometrium, the microbiota of the genital t... | ||
Medical condition: Female infertility | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.